VERTEX PHARMACEUTICALS INC / MA Extraordinary Item, Earnings Per Share Impact, Net (Deprecated 2019-01-31)
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Extraordinary Item, Earnings Per Share Impact, Net (Deprecated 2019-01-31) of $1.28 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:ExtraordinaryItemEarningsPerShareImpactNet · last filed 2014-07-31
- VERTEX PHARMACEUTICALS INC / MA extraordinary item, earnings per share impact, net (deprecated 2019-01-31) for the quarter ending 2013-03-31 was $1.32.
USD
| Period end | Extraordinary Item, Earnings Per Share Impact, Net (Deprecated 2019-01-31) 3 month | Extraordinary Item, Earnings Per Share Impact, Net (Deprecated 2019-01-31) 6 month | Extraordinary Item, Earnings Per Share Impact, Net (Deprecated 2019-01-31) 9 month |
|---|---|---|---|
| 2013-09-30 | $1.28K 10-Q · filed 2013-11-07 | ||
| 2013-06-30 | $1.30 10-Q · filed 2014-07-31 | ||
| 2013-03-31 | $1.32 10-Q · filed 2014-05-05 |
USD/shares
| Period end | Extraordinary Item, Earnings Per Share Impact, Net (Deprecated 2019-01-31) 6 month |
|---|---|
| 2013-06-30 | $1.30 10-Q · filed 2014-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |